SNT 25.7% 4.4¢ syntara limited

its great news if the results are good as they don't need any...

  1. 137 Posts.

    its great news if the results are good as they don't need any further approval from EU, Aust as they just simply apply for lable extention. Also, they won't get approval from FDA on mar 18 (IMO) as they can't re-submit after their original submission so they have to approve the whole lot rather than 18+, its just the way the FDA works...they will have to re-submit and probably do it a few months after maybe Oct and hopefully no extra trials. Its a process and its complicated but thats the way it works...don't get spooked, the're ok and they will recover...
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.